BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15911867)

  • 1. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation.
    Oktay K
    J Clin Oncol; 2005 Jun; 23(16):3858-9. PubMed ID: 15911867
    [No Abstract]   [Full Text] [Related]  

  • 2. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen.
    Oktay K; Buyuk E; Davis O; Yermakova I; Veeck L; Rosenwaks Z
    Hum Reprod; 2003 Jan; 18(1):90-5. PubMed ID: 12525446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.
    Oktay K; Hourvitz A; Sahin G; Oktem O; Safro B; Cil A; Bang H
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3885-90. PubMed ID: 16882752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.
    Oktay K; Buyuk E; Libertella N; Akar M; Rosenwaks Z
    J Clin Oncol; 2005 Jul; 23(19):4347-53. PubMed ID: 15824416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility preservation in women with breast cancer.
    Rodriguez-Wallberg KA; Oktay K
    Clin Obstet Gynecol; 2010 Dec; 53(4):753-62. PubMed ID: 21048442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.
    Turan V; Bedoschi G; Emirdar V; Moy F; Oktay K
    Reprod Sci; 2018 Jan; 25(1):26-32. PubMed ID: 28874104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer.
    Oktay K; Turan V; Bedoschi G; Pacheco FS; Moy F
    J Clin Oncol; 2015 Aug; 33(22):2424-9. PubMed ID: 26101247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
    Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
    Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.
    Azim AA; Costantini-Ferrando M; Oktay K
    J Clin Oncol; 2008 Jun; 26(16):2630-5. PubMed ID: 18509175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate.
    Fatum M; McVeigh E; Child T
    Hum Fertil (Camb); 2013 Dec; 16(4):235-40. PubMed ID: 23863119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fertility preservation in breast cancer patients by embryo cryopreservation after ovarian stimulation with letrozole and FSH].
    Beckmann MW; Findeklee S
    Strahlenther Onkol; 2015 Nov; 191(11):895-6. PubMed ID: 26400478
    [No Abstract]   [Full Text] [Related]  

  • 13. Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial.
    Letourneau J; Juarez-Hernandez F; Wald K; Ribeiro S; Wang A; McCulloch CE; Mok-Lin E; Dolezal M; Chien AJ; Cedars MI; Rosen M
    J Assist Reprod Genet; 2021 Sep; 38(9):2455-2463. PubMed ID: 34312774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of letrozole or tamoxifen coadministered with a standard stimulation protocol on fertility preservation among breast cancer patients.
    Shulman Y; Almog B; Kalma Y; Fouks Y; Azem F; Cohen Y
    J Assist Reprod Genet; 2021 Mar; 38(3):743-750. PubMed ID: 33409757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?
    Revelli A; Porcu E; Levi Setti PE; Delle Piane L; Merlo DF; Anserini P
    Gynecol Endocrinol; 2013 Nov; 29(11):993-6. PubMed ID: 24000936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction.
    Dahhan T; Balkenende E; van Wely M; Linn S; Goddijn M
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010240. PubMed ID: 24213953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.
    Dahhan T; Balkenende EME; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; van Golde RJT; Schipper I; Louwé LA; Cantineau AEP; Smeenk JMJ; de Bruin JP; Reddy N; Kopeika Y; van der Veen F; van Wely M; Linn SC; Goddijn M
    Contemp Clin Trials; 2017 Oct; 61():96-100. PubMed ID: 28710053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization.
    Azim AA; Costantini-Ferrando M; Lostritto K; Oktay K
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2197-200. PubMed ID: 17356042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes†.
    Pereira N; Hancock K; Cordeiro CN; Lekovich JP; Schattman GL; Rosenwaks Z
    Gynecol Endocrinol; 2016 Oct; 32(10):823-826. PubMed ID: 27114051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma.
    Azim A; Oktay K
    Fertil Steril; 2007 Sep; 88(3):657-64. PubMed ID: 17428480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.